CYTOKINE-STIMULATION OF PROSTAGLANDIN SYNTHESIS FROM ENDOGENOUS AND EXOGENOUS ARACHIDONIC ACIDS IN POLYMORPHONUCLEAR LEUKOCYTES INVOLVING ACTIVATION AND NEW SYNTHESIS OF CYCLOOXYGENASE

被引:54
作者
HERRMANN, F [1 ]
LINDEMANN, A [1 ]
GAUSS, J [1 ]
MERTELSMANN, R [1 ]
机构
[1] UNIV MAINZ,DEPT HEMATOL,W-6500 MAINZ,GERMANY
关键词
D O I
10.1002/eji.1830201124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peripheral blood‐derived human polymorphonuclear leukocytes (PMNL) can be induced to synthesize prostaglandin E2 (PGE2) from endogenous and exogenous arachidonic acid (AA) when exposed to agents such as human recombinant (hr) granulocyte‐macrophage (GM) colony‐stimulating factor (CSF), hr tumor necrosis factor‐α, hr granulocyte (G)‐CSF, lipopolysaccharide and the chemoattractant N‐formyl‐methionyl‐leucyl‐phenylalanine. Treatment of PMNL with hr macrophage (M)‐CSF and interleukin 3, however, did not result in detectable PGE2 synthesis. Cytokines stimulated PGE2 production during two distinct time intervals, an early peak of PGE2 that was detectable at 20 min and a late one detectable after 4 h. Inhibition of protein synthesis by cycloheximide (CHX) had virtually no effect on the early increase of PGE2 but prevented the late increase. Late addition of CHX to cultures after stimulation with hr GM‐CSF at 4 h resulted in decline of PGE2 synthesis from exogenous arachidonic acid. Treatment of PMNL with GM‐CSF had direct effects on cyclooxygenase (COx). PMNL depleted from COx by acetyl salicylic acid (ASA) recovered to synthesize PGE2 following exposure to GM‐CSF. Recovery from COx inhibition by ASA could be prevented by CHX. Copyright © 1990 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
引用
收藏
页码:2513 / 2516
页数:4
相关论文
共 19 条
[1]  
BAILEY JM, 1984, KYOTO C PROSTAGLANDI, P52
[2]  
BERTANI A, 1989, BLOOD, V74, P1811
[3]   PROSTACYCLIN BIOSYNTHESIS IN CULTURED VASCULAR ENDOTHELIUM IS LIMITED BY DEACTIVATION OF CYCLOOXYGENASE [J].
BROTHERTON, AFA ;
HOAK, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (04) :1255-1261
[4]  
CICCO NA, 1990, BLOOD, V75, P2049
[5]   EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
SCHER, H ;
STERNBERG, C ;
WONG, G ;
GROUS, J ;
YAGODA, A ;
FAIN, K ;
MOORE, MAS ;
CLARKSON, B ;
OETTGEN, HF ;
ALTON, K ;
WELTE, K ;
SOUZA, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422
[6]  
Granstrom E, 1978, Adv Prostaglandin Thromboxane Res, V5, P119
[7]   HUMAN PLATELET-DERIVED GROWTH-FACTOR STIMULATES PROSTAGLANDIN SYNTHESIS BY ACTIVATION AND BY RAPID DENOVO SYNTHESIS OF CYCLOOXYGENASE [J].
HABENICHT, AJR ;
GOERIG, M ;
GRULICH, J ;
ROTHE, D ;
GRONWALD, R ;
LOTH, U ;
SCHETTLER, G ;
KOMMERELL, B ;
ROSS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) :1381-1387
[8]  
HEIDORN K, 1987, BLOOD, V70, P456
[9]   HEMATOPOIETIC RESPONSES IN PATIENTS WITH ADVANCED MALIGNANCY TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].
HERRMANN, F ;
SCHULZ, G ;
LINDEMANN, A ;
MEYENBURG, W ;
OSTER, W ;
KRUMWIEH, D ;
MERTELSMANN, R .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :159-167
[10]  
IRVINE RF, 1982, BIOCHEM J, V3, P204